Scientists from MedGenome, Genentech and Madras Institute of Technology in India have spotted a biomarker that may help avoid misdiagnosis of Type 1 diabetes in children. Those with Maturity Onset Diabetes of the Young (MODY) have different treatment needs than Type 1 requires, but a genomic analysis like the one done by the researchers can help differentiate between the two closely related diseases.
Image: HNF1B deletion in a MODY patient. Copy number analysis of MODY sample MDX 0042. Courtesy of researchers.
Study in BMC Medical Genetics: Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India…
